Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SURG vs TMUS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SURG
SurgePays, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$11M
5Y Perf.-96.4%
TMUS
T-Mobile US, Inc.

Telecommunications Services

Communication ServicesNASDAQ • US
Market Cap$210.16B
5Y Perf.+94.1%

SURG vs TMUS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SURG logoSURG
TMUS logoTMUS
IndustrySoftware - ApplicationTelecommunications Services
Market Cap$11M$210.16B
Revenue (TTM)$50M$90.53B
Net Income (TTM)$-42M$10.54B
Gross Margin-38.6%54.3%
Operating Margin-78.8%20.4%
Forward P/E18.5x
Total Debt$5M$122.27B
Cash & Equiv.$12M$5.60B

SURG vs TMUSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SURG
TMUS
StockMay 20May 26Return
SurgePays, Inc. (SURG)1003.6-96.4%
T-Mobile US, Inc. (TMUS)100194.1+94.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: SURG vs TMUS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: TMUS leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. SurgePays, Inc. is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SURG
SurgePays, Inc.
The Defensive Pick

SURG is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.30, Low D/E 30.1%, current ratio 2.95x
  • Beta 1.30, current ratio 2.95x
  • Lower D/E ratio (30.1% vs 206.5%)
Best for: sleep-well-at-night and defensive
TMUS
T-Mobile US, Inc.
The Growth Play

TMUS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 8.5%, EPS growth 0.6%, 3Y rev CAGR 3.5%
  • 407.2% 10Y total return vs SURG's -99.1%
  • 8.5% revenue growth vs SURG's -55.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthTMUS logoTMUS8.5% revenue growth vs SURG's -55.6%
Quality / MarginsTMUS logoTMUS11.6% margin vs SURG's -83.4%
Stability / SafetySURG logoSURGLower D/E ratio (30.1% vs 206.5%)
DividendsTMUS logoTMUS1.9% yield; 3-year raise streak; the other pay no meaningful dividend
Momentum (1Y)TMUS logoTMUS-21.2% vs SURG's -78.9%
Efficiency (ROA)TMUS logoTMUS4.9% ROA vs SURG's -242.4%, ROIC 8.1% vs -229.7%

SURG vs TMUS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SURGSurgePays, Inc.
FY 2023
Lead Generation
100.0%$7M
TMUST-Mobile US, Inc.
FY 2025
Branded Postpaid Revenue
65.6%$57.9B
Product, Equipment
18.1%$16.0B
Branded Prepaid Revenue
11.9%$10.5B
Wholesale Service Revenue
3.3%$2.9B
Product and Service, Other
1.2%$1.0B

SURG vs TMUS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLTMUSLAGGINGSURG

Income & Cash Flow (Last 12 Months)

TMUS leads this category, winning 4 of 6 comparable metrics.

TMUS is the larger business by revenue, generating $90.5B annually — 1797.2x SURG's $50M. TMUS is the more profitable business, keeping 11.6% of every revenue dollar as net income compared to SURG's -83.4%. On growth, SURG holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSURG logoSURGSurgePays, Inc.TMUS logoTMUST-Mobile US, Inc.
RevenueTrailing 12 months$50M$90.5B
EBITDAEarnings before interest/tax-$39M$29.9B
Net IncomeAfter-tax profit-$42M$10.5B
Free Cash FlowCash after capex-$26M$10.7B
Gross MarginGross profit ÷ Revenue-38.6%+54.3%
Operating MarginEBIT ÷ Revenue-78.8%+20.4%
Net MarginNet income ÷ Revenue-83.4%+11.6%
FCF MarginFCF ÷ Revenue-50.9%+11.8%
Rev. Growth (YoY)Latest quarter vs prior year+2.9%+10.6%
EPS Growth (YoY)Latest quarter vs prior year+47.2%-12.0%
TMUS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

SURG leads this category, winning 3 of 3 comparable metrics.
MetricSURG logoSURGSurgePays, Inc.TMUS logoTMUST-Mobile US, Inc.
Market CapShares × price$11M$210.2B
Enterprise ValueMkt cap + debt − cash$4M$326.8B
Trailing P/EPrice ÷ TTM EPS-0.23x19.98x
Forward P/EPrice ÷ next-FY EPS est.18.45x
PEG RatioP/E ÷ EPS growth rate0.67x
EV / EBITDAEnterprise value multiple10.13x
Price / SalesMarket cap ÷ Revenue0.18x2.38x
Price / BookPrice ÷ Book value/share0.70x3.71x
Price / FCFMarket cap ÷ FCF20.32x
SURG leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

TMUS leads this category, winning 6 of 9 comparable metrics.

TMUS delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-10 for SURG. SURG carries lower financial leverage with a 0.30x debt-to-equity ratio, signaling a more conservative balance sheet compared to TMUS's 2.07x. On the Piotroski fundamental quality scale (0–9), TMUS scores 6/9 vs SURG's 2/9, reflecting solid financial health.

MetricSURG logoSURGSurgePays, Inc.TMUS logoTMUST-Mobile US, Inc.
ROE (TTM)Return on equity-10.1%+17.8%
ROA (TTM)Return on assets-2.4%+4.9%
ROICReturn on invested capital-2.3%+8.1%
ROCEReturn on capital employed-177.3%+9.8%
Piotroski ScoreFundamental quality 0–926
Debt / EquityFinancial leverage0.30x2.07x
Net DebtTotal debt minus cash-$7M$116.7B
Cash & Equiv.Liquid assets$12M$5.6B
Total DebtShort + long-term debt$5M$122.3B
Interest CoverageEBIT ÷ Interest expense-40.65x5.33x
TMUS leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

TMUS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in TMUS five years ago would be worth $14,546 today (with dividends reinvested), compared to $715 for SURG. Over the past 12 months, TMUS leads with a -21.2% total return vs SURG's -78.9%. The 3-year compound annual growth rate (CAGR) favors TMUS at 12.0% vs SURG's -49.3% — a key indicator of consistent wealth creation.

MetricSURG logoSURGSurgePays, Inc.TMUS logoTMUST-Mobile US, Inc.
YTD ReturnYear-to-date-67.4%-2.2%
1-Year ReturnPast 12 months-78.9%-21.2%
3-Year ReturnCumulative with dividends-86.9%+40.4%
5-Year ReturnCumulative with dividends-92.8%+45.5%
10-Year ReturnCumulative with dividends-99.1%+407.2%
CAGR (3Y)Annualised 3-year return-49.3%+12.0%
TMUS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

TMUS leads this category, winning 2 of 2 comparable metrics.

TMUS is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than SURG's 1.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TMUS currently trades 74.2% from its 52-week high vs SURG's 16.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSURG logoSURGSurgePays, Inc.TMUS logoTMUST-Mobile US, Inc.
Beta (5Y)Sensitivity to S&P 5001.30x-0.28x
52-Week HighHighest price in past year$3.45$261.56
52-Week LowLowest price in past year$0.46$181.36
% of 52W HighCurrent price vs 52-week peak+16.2%+74.2%
RSI (14)Momentum oscillator 0–10039.945.5
Avg Volume (50D)Average daily shares traded378K5.6M
TMUS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

TMUS is the only dividend payer here at 1.88% yield — a key consideration for income-focused portfolios.

MetricSURG logoSURGSurgePays, Inc.TMUS logoTMUST-Mobile US, Inc.
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$254.08
# AnalystsCovering analysts54
Dividend YieldAnnual dividend ÷ price+1.9%
Dividend StreakConsecutive years of raises3
Dividend / ShareAnnual DPS$3.64
Buyback YieldShare repurchases ÷ mkt cap+5.6%+4.7%
Insufficient data to determine a leader in this category.
Key Takeaway

TMUS leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SURG leads in 1 (Valuation Metrics).

Best OverallT-Mobile US, Inc. (TMUS)Leads 4 of 6 categories
Loading custom metrics...

SURG vs TMUS: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is SURG or TMUS a better buy right now?

For growth investors, T-Mobile US, Inc.

(TMUS) is the stronger pick with 8. 5% revenue growth year-over-year, versus -55. 6% for SurgePays, Inc. (SURG). T-Mobile US, Inc. (TMUS) offers the better valuation at 20. 0x trailing P/E (18. 5x forward), making it the more compelling value choice. Analysts rate T-Mobile US, Inc. (TMUS) a "Buy" — based on 54 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SURG or TMUS?

Over the past 5 years, T-Mobile US, Inc.

(TMUS) delivered a total return of +45. 5%, compared to -92. 8% for SurgePays, Inc. (SURG). Over 10 years, the gap is even starker: TMUS returned +407. 2% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SURG or TMUS?

By beta (market sensitivity over 5 years), T-Mobile US, Inc.

(TMUS) is the lower-risk stock at -0. 28β versus SurgePays, Inc. 's 1. 30β — meaning SURG is approximately -565% more volatile than TMUS relative to the S&P 500. On balance sheet safety, SurgePays, Inc. (SURG) carries a lower debt/equity ratio of 30% versus 2% for T-Mobile US, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — SURG or TMUS?

By revenue growth (latest reported year), T-Mobile US, Inc.

(TMUS) is pulling ahead at 8. 5% versus -55. 6% for SurgePays, Inc. (SURG). On earnings-per-share growth, the picture is similar: T-Mobile US, Inc. grew EPS 0. 6% year-over-year, compared to -273. 2% for SurgePays, Inc.. Over a 3-year CAGR, SURG leads at 6. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SURG or TMUS?

T-Mobile US, Inc.

(TMUS) is the more profitable company, earning 12. 4% net margin versus -75. 1% for SurgePays, Inc. — meaning it keeps 12. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TMUS leads at 21. 2% versus -68. 6% for SURG. At the gross margin level — before operating expenses — TMUS leads at 47. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SURG or TMUS?

In this comparison, TMUS (1.

9% yield) pays a dividend. SURG does not pay a meaningful dividend and should not be held primarily for income.

07

Is SURG or TMUS better for a retirement portfolio?

For long-horizon retirement investors, T-Mobile US, Inc.

(TMUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 1. 9% yield, +407. 2% 10Y return). Both have compounded well over 10 years (TMUS: +407. 2%, SURG: -99. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SURG and TMUS?

These companies operate in different sectors (SURG (Technology) and TMUS (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

TMUS pays a dividend while SURG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SURG

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 145%
Run This Screen
Stocks Like

TMUS

Income & Dividend Stock

  • Sector: Communication Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SURG and TMUS on the metrics below

Revenue Growth>
%
(SURG: 291.6% · TMUS: 10.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.